Joseph D. Korshalla is a notable inventor based in Pearl River, NY (US). He has made significant contributions to the field of antibiotics, holding a total of 3 patents. His work has been instrumental in advancing medical treatments through innovative antibiotic solutions.

Latest Patents

Korshalla's latest patents include the antibiotic LL-E19020 Gamma, which is derived from the microorganism Streptomyces lydicus ssp. tanzanius NRRL 18036. This invention provides a new avenue for antibiotic treatment. Another significant patent is the antibiotic LL-E19020 Alpha.sub.1, also derived from the same microorganism. Both inventions showcase his dedication to improving healthcare through scientific innovation.

Career Highlights

Throughout his career, Korshalla has worked with prominent companies such as Roche Vitamins Inc. and American Cyanamid Company. His experience in these organizations has allowed him to develop and refine his expertise in antibiotic research and development.

Collaborations

Korshalla has collaborated with notable coworkers, including David R. Williams and John H. Martin. Their combined efforts have contributed to the success of various projects in the field of antibiotic development.

Conclusion

Joseph D. Korshalla's contributions to antibiotic innovation highlight his role as a key figure in the medical research community. His patents and collaborations reflect a commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]